Managing Alcohol Withdrawal and Dependence with Anxiety in Indian Patients

Overview

This review synthesizes expert opinions and literature to guide physicians and psychiatrists in India on managing alcohol withdrawal syndrome (AWS), alcohol dependence (AD), and AD with co-morbid anxiety. It emphasizes accurate diagnosis, distinct treatment pathways, and collaborative care to reduce relapse and improve outcomes.

Background

Alcohol dependence (AD) presents complex physical and psychiatric challenges, including alcohol withdrawal syndrome (AWS) and co-morbid anxiety, which complicate treatment. India faces a growing burden of AD-related disorders, with significant morbidity and mortality. Physicians often serve as the first contact for patients but lack clear management protocols distinct from psychiatric care. A holistic, multidisciplinary approach is needed to address the multifaceted nature of AD and its complications effectively.

Data Highlights

A series of five focus group discussions involving 57 expert physicians and psychiatrists across India informed the review. These experts contributed to developing screening, diagnosis, and treatment algorithms tailored for AWS, AD, and AD with anxiety. The discussions highlighted the prevalence of AD-related disorders, challenges in clinical management, and the need for integrated care pathways.

Key Findings

• Benzodiazepines, particularly long-acting agents like chlordiazepoxide, remain the cornerstone of detoxification for AWS and AD.
• Distinct screening tools, symptom inventories, and laboratory investigations are essential for differentiating AWS, AD, and AD with anxiety.
• Physicians play a critical role as first-line providers but should collaborate closely with psychiatrists, especially for severe psychiatric comorbidities or complicated withdrawal.
• AD with co-existing anxiety requires specialized diagnostic and therapeutic approaches due to limited clinical evidence and higher relapse risk.
• A holistic management strategy encompassing physical, psychiatric, and behavioral aspects can reduce relapse rates and improve patient outcomes.
• Regional expert consensus in India supports tailored algorithms that consider local epidemiology and healthcare infrastructure.

Clinical Implications

Clinicians should employ comprehensive screening and diagnostic protocols to distinguish between AWS, AD, and AD with anxiety, enabling targeted treatment. Benzodiazepines remain the mainstay for detoxification, but referral to psychiatry is warranted for complex cases. Collaborative, multidisciplinary care models are essential to address the multifactorial nature of alcohol use disorders and reduce relapse.

Conclusion

This narrative review provides evidence- and expert-based guidance for managing AWS, AD, and AD with anxiety in Indian clinical settings. Implementing integrated, tailored approaches can optimize treatment outcomes and address the growing burden of alcohol-related disorders.

References

1. Expert Panel/2025 -- A Comprehensive Approach to Managing Alcohol Withdrawal Syndrome and Alcohol Dependence with Anxiety in Indian Patients